635.59998 EUR
10.6
1.64%
Last update Dec 16, 9:19 AM CET
Main market
Day range
635.59998
635.59998
Previous close
646.20001
Open
635.59998
Access this stock data via API
Subscribe
Regeneron Pharmaceuticals, Inc.
635.60
10.60
1.64%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 12.1B 13.1B 12.2B 16.1B
Cost of revenue 1.7B 1.8B 1.6B 2.4B
Gross profit 10.4B 11.3B 10.6B 13.6B
Operating expense
Research & development 4.5B 4.4B 3.6B 2.9B
Selling general and admin 2.5B 2.6B 2.1B 1.8B
Other operating expenses 45.5M -2.1M -89.9M -45.6M
Operating income 3.4B 4.2B 5.0B 9.0B
Non operating interest income
Income 606.3M 495.9M 160.1M 45.8M
Expense 47.0M 73M 59.4M 57.3M
Other income expense 113.3M -456.8M -235.9M 342.5M
Pretax income 4.1B 4.2B 4.9B 9.3B
Tax provision 313.0M 245.7M 520.4M 1.3B
Net income 3.8B 4.0B 4.3B 8.1B
Basic EPS 40.9 37.1 40.5 76.4
Diluted EPS 38.3 34.8 38.2 72.0
Basic average shares 92.0M 110.8M 110.0M 108.5M
Diluted average shares 92.0M 110.8M 110.0M 108.5M
EBITDA 4.4B 5.1B 5.5B 9.3B
Net income from continuing op. 3.8B 4.0B 4.3B 8.1B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 9 hours 51 minutes

12:08
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).